said has set distribution system ensure people most can retrovir first drug have activity against aids during initial period while supplies drug limited press conference paul dreyer company product manager for drug said physicians must submit enrollment application company for each new patient candidate for taking drug company arm wellcome plc application will list several items required evaluate patient company will inform doctors within week patient meets enrollment criteria and whether sufficient amounts drug available friday food and drug administration approved drug for wide clinical drug not cure for aids but does prolong lives certain people with aids have history certain types pneumonia and patients with advanced form aids related complex whose immune systems have declined after infection with virus company said only has enough supply drug treat 000 patients and end year should have enough supply treat 000 patients dreyer said physicians can call 800 843 9388 for information about distribution drug and pharmacists can call 800 322 1887 orders for drug dreyer added this distribution system will end once adequate supply drug available thomas kennedy vice president corporate affairs declined comment cost developing drug some organizations have criticized high cost drug which said between 000 and 000 dlrs per year for treatment dreyer said took seven months drug and company obtained principal raw material from pfizer inc dryer said company developing suppliers company said spent mln dlrs for raw materials for drug and undisclosed amount research but would not disclose total cost developing retrovir burroughs has cited high cost making drug reasons for its cost reuter 